发明名称 Therapeutic methods employing nitric oxide precursors
摘要 <p>Abstract of the Disclosure Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a 5 human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) 10 associated with bone marrow transplants. 3454000_1 (GHMoter) P01593AU2 LMfOchondno HO3+NH4+2AT CPSI 0 0 N-ac tyilutarnate cAc" Phshte Aspartic OmithineArginosuccinote ARGinn ASL Urea Fumorote FIG, I $1 .0 4f ADP ox Ph sI ot Carbaoy Phosphate FIG, 2</p>
申请公布号 AU2012203629(B2) 申请公布日期 2015.01.29
申请号 AU20120203629 申请日期 2012.06.21
申请人 VANDERBILT UNIVERSITY 发明人 SUMMAR, MARSHALL L.;CHRISTMAN, BRIAN;BARR, FREDERICK E.
分类号 A61K31/195;C07H21/04;C12N9/12;C12Q1/68 主分类号 A61K31/195
代理机构 代理人
主权项
地址